Directed investment, the path.docVIP

 PAGE \* MERGEFORMAT 4 Directed investment, the path Investment developing now, having gone through a continued brilliance once again into the confusion and confused period. With the new medical reform “basic medicine system”, “two votes” system, “three control measures” and universal health care and constant regulation of drug prices Merchants agency how the future development of the debate has heated up. However, as the current medicine production enterprises, commercial enterprises, and reallocation of resources among individual agents and strategic agency formed under the integration, I never doubt the vitality. And, in recent years emerged from the distinctive characteristics of corporate investment patterns and investment companies listed on fashion point of view, the pharmaceutical industry’s investment model has strong adaptability and vitality, the key advantage of the opportunity to see how the development of enterprise and innovation. At the same time, we should clearly see that from the “Phone + ad + event” started to gradually suited to the traditional investment model has a current market environment. Instead, the combat system modernization has been under taken, some heavy, precise focus of the “directed investment model”, for those small-scale enterprises, investment, intensive farming, or the one hand, the success of a market much larger than the comprehensive net better chance to build their own capital to survive. And return to research investment involves three key components: product, promotion, service aspects, it is easy to tease out the “targeted investment” of several operating path. First, the product can not be brought the matter on behalf of the Investment companies is the key to the existence and operation of products, investment products as a constraint to business development is all about. So for the investment enterprises, the direction of seeking new product positioning, investment companies need to be careful considera